National Cancer Testing Solution
Closed Pre-Solicitation Posted
- Solicitation number
- 36C10X26Q0084
- Agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Frederick, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Strategic Acquisition Center Frederick is seeking a National Cancer Testing Solution to address critical gaps in laboratory diagnostic capabilities for the NPOP Precision Oncology Program. The procurement focuses on comprehensive cancer testing services across 27 solid tumor malignancies and 20 hematologic malignancies, with particular emphasis on closing significant testing modality gaps including immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), next-generation sequencing (NGS) panels, PCR-based tests, karyotyping/cytogenetics, flow cytometry, and methylation testing. Vendors must demonstrate core competencies in medical laboratory testing, provide detailed information on their testing capabilities, relevant experience with comparable projects, and commercial pricing data. The government is conducting market research through this sources sought notice to inform future acquisition decisions; this is not a formal solicitation and does not commit the government to contract. Interested parties must submit responses by March 17, 2026, via email to designated government contacts, with no phone calls permitted.
This pre-solicitation notice carries no small business set-aside designation and does not identify any incumbent contractors. The notice does not establish a specific contract award value or budget range, as it remains in the preliminary market research phase. However, the clinical volume requirements are substantial, with major disease categories including head and neck cancer (2,700 annual cases), melanoma (4,300 cases), colorectal cancer (400 cases), and esophageal cancer (1,000 cases), indicating significant service delivery demands. All hematologic malignancies currently present major gaps in testing coverage, suggesting comprehensive unmet laboratory service needs. The NAICS classification is Medical Laboratories (621511) with the PSC code Q301 for Reference Laboratory Testing, establishing the primary acquisition category for potential contractors to align their business classifications and capabilities accordingly.
Notice text
Please see attachments for sources sourght information.
Files
| File | Type | Posted |
|---|---|---|
| 2026 NPOP Complete_Disease_Coverage_Attachment.docx | DOCX document | |
| SOURCES SOUGHT 2025 NPOP Complete_Disease_Coverage.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NCI 2026 Cervical Cancer Screening Follow-Up | National Cancer Institute | No set-aside | |
| 6640--karius test | Veterans Integrated Service Network 8 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity